THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 127 filers reported holding THERAVANCE INC in Q3 2014. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $53,000 | -73.5% | 7,374 | -33.3% | 0.00% | – |
Q2 2015 | $200,000 | +440.5% | 11,061 | +375.3% | 0.00% | – |
Q1 2015 | $37,000 | -19.6% | 2,327 | -13.8% | 0.00% | – |
Q3 2014 | $46,000 | -22.0% | 2,700 | 0.0% | 0.00% | – |
Q2 2014 | $59,000 | +55.3% | 2,700 | +90.7% | 0.00% | – |
Q1 2014 | $38,000 | -17.4% | 1,416 | +12.6% | 0.00% | – |
Q4 2013 | $46,000 | -97.2% | 1,258 | -96.9% | 0.00% | -100.0% |
Q3 2013 | $1,645,000 | -3.9% | 40,233 | -9.4% | 0.00% | 0.0% |
Q2 2013 | $1,711,000 | – | 44,424 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |